- Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment
-
Komori A, Kugiyama Y
- KMID: 2563409
- Clin Mol Hepatol.
- 2025 Jan;31(1):90-104.
- doi: 10.3350/cmh.2024.0821
Patients with hard-to-treat autoimmune hepatitis (AIH) or primary biliary cholangitis (PBC) are defined a posteriori as those who do not show a sufficient response or are intolerant to pharmacological treatments,... -
- CITED
-
- Close
- SHARE
-
- Close
